Invention Publication
![CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND](/docs/US/2023-06-29/US20230201181A1/abs.jpg.600x600.jpg)
- Patent Title: CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND
-
Application No.: US18115436Application Date: 2023-02-28
-
Publication No.: US20230201181A1Publication Date: 2023-06-29
- Inventor: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
- Applicant Address: US CA South San Francisco
- Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- The original application number of the division: US14060846 2013.10.23
- Main IPC: A61K31/4465
- IPC: A61K31/4465 ; C07D211/22 ; C07D211/32
![CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND](/abs-image/US/2023/06/29/US20230201181A1/abs.jpg.150x150.jpg)
Abstract:
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
Information query
IPC分类:
